U.S., Feb. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07382843) titled 'Melatonin Agonist for Shift-time Workers.' on Sept. 03, 2025.
Brief Summary: The study of the relationship between sleep pattern, attention performance, and heart rate variability among night workers.
Study Start Date: March 04, 2024
Study Type: INTERVENTIONAL
Condition:
Circadian Rhythm Disorders
Intervention:
DRUG: Ramelteon
comparison of anxiety/depression, insomnia symptoms severity between before and after treatment with 8mg Ramelteon per day for two weeks among shift time workers.
Recruitment Status: COMPLETED
Sponsor: Tri-Service General Hospital
Information provided by (Responsible Party): Chin-Bin Yeh, MD, PhD, Tri...